Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Liabilities and Shareholders Equity (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Liabilities and Shareholders Equity readings, the most recent being $190.6 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 12.21% to $190.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $799.5 million, a 11.06% decrease, with the full-year FY2025 number at $190.6 million, down 12.21% from a year prior.
  • Liabilities and Shareholders Equity hit $190.6 million in Q4 2025 for Treace Medical Concepts, down from $196.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $251.9 million in Q4 2023 to a low of $37.4 million in Q1 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $201.2 million (2025), compared with a mean of $188.4 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 291.93% in 2022 and later decreased 15.19% in 2025.
  • Treace Medical Concepts' Liabilities and Shareholders Equity stood at $140.8 million in 2021, then rose by 12.93% to $159.0 million in 2022, then surged by 58.41% to $251.9 million in 2023, then decreased by 13.82% to $217.1 million in 2024, then fell by 12.21% to $190.6 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $190.6 million (Q4 2025), $196.6 million (Q3 2025), and $206.4 million (Q2 2025) per Business Quant data.